Article
Exploring the synergistic behaviour of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management
2023-05-24
Abstract excerpt
<title>Abstract</title> <p>Breast cancer is challenging to treat accompanied with poor clinical outcomes. Paclitaxel (PTX) is a first-line chemotherapeutic agent, but possesses limitations due to side effects, high dose, non-specific tissue distribution, and drug resistance. An epigenetic modulator, Vorinostat (VOR) is known to enhance PTX efficacy and therefore to resolve the issues of conventional PTX formulati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b00bb165-4781-500f-acd1-d8ed82593567
- DOI
- 10.21203/rs.3.rs-2928600/v1
